Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.80 |
| ▸ | POLB | P06746 | 1/20 | 0.80 |
| ▸ | MAOB | P27338 | 8/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.61 |
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | NT5E | P21589 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA3 | P07451 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | CA6 | P23280 | 1/20 | 0.58 |
| ▸ | CA5A | P35218 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL95179 | 0.89 | SMN1; SMN2 (1.00) | SMN1; SMN2POLBMAOBKDM4ECA12 | |
| SCHEMBL31072059 | 0.89 | SMN1; SMN2 (1.00) | SMN1; SMN2POLBMAOBKDM4ECA12 | |
| Alanine SCHEMBL8945631 | 0.88 | POLB (0.71) | SMN1; SMN2POLBMAOBKDM4ECA12 | |
| Ammonia Solution, Strong SCHEMBL12076949 | 0.88 | SMN1; SMN2 (0.96) | SMN1; SMN2POLBMAOBKDM4ECA12 | |
| Chlorobenzene SCHEMBL27886636 | 0.83 | SMN1; SMN2 (0.80) | SMN1; SMN2POLBMAOBKDM4ECA12 | |
| 3-Hydroxycoumarin SCHEMBL6401867 | 0.81 | HPGD (0.83) | SMN1; SMN2POLBMAOBKDM4ECA12 | |
| Acetic Acid SCHEMBL1698232 | 0.81 | MAOB (0.63) | SMN1; SMN2POLBMAOBKDM4ECA12 | |
| Acetic Acid SCHEMBL8657413 | 0.81 | FLT3 (0.56) | SMN1; SMN2POLBMAOBKDM4ECA12 | |
| Acetic Acid SCHEMBL27818374 | 0.81 | MAOB (0.63) | SMN1; SMN2POLBMAOBCA12CA9 | |
| Coumarin SCHEMBL27715683 | 0.80 | SMN1; SMN2 (0.80) | SMN1; SMN2POLBMAOBKDM4ECA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0975803-A4 | METHOD FOR ASSESSING PROSTATE CANCER | ALBANY MEDICAL COLLEGE (US) | 2002-01-16 | — | — | EP | claimed |
| EP-0975803-A1 | METHOD FOR ASSESSING PROSTATE CANCER | ALBANY MEDICAL COLLEGE (US) | 2000-02-02 | — | — | EP | claimed |
| US-5994071-A | MEASURING AMPLIFICATION LEVELS OF A TYROSINE KINASE GROWTH FACTOR REGULATOR GENE IN TISSUE SAMPLES USING FLUORESCENCE IN SITU HYBRIDIZATION, EVALUATING LEVELS WITH A REFERENCE LEVEL OF NORMAL CELLS; INCREASED LEVELS INDICATE RECURRENCE | ALBANY MEDICAL COLLEGE (US) | 1999-11-30 | — | — | US | claimed |
| WO-1998045479-A1 | METHOD FOR ASSESSING PROSTATE CANCER | ALBANY MEDICAL COLLEGE (US) | 1998-10-15 | — | — | WO | claimed |
| EP-3768079-B1 | TRANSGENIC CHICKEN THAT PRODUCES HUMAN ANTIBODIES | CRYSTAL BIOSCIENCE INC (US) | 2026-04-29 | — | — | EP | disclosed |
| CN-112004411-B | Transgenic chicken producing human antibody | 晶体生物科学股份有限公司 | 2023-05-26 | — | — | CN | disclosed |
| EP-3768079-A1 | TRANSGENIC CHICKEN THAT PRODUCES HUMAN ANTIBODIES | Crystal Bioscience Inc. (US) | 2021-01-27 | — | — | EP | disclosed |
| US-20210000088-A1 | TRANSGENIC CHICKEN THAT PRODUCES HUMAN ANTIBODIES | CRYSTAL BIOSCIENCE INC. | 2021-01-07 | — | — | US | disclosed |
| CN-112004411-A | Human antibody-producing transgenic chickens | 晶体生物科学股份有限公司 | 2020-11-27 | — | — | CN | disclosed |
| US-10687519-B2 | Transgenic animal for production of antibodies having minimal CDRs | CRYSTAL BIOSCIENCE INC. (US) | 2020-06-23 | — | — | US | disclosed |
| US-20190320630-A1 | TRANSGENIC ANIMAL FOR PRODUCTION OF ANTIBODIES HAVING MINIMAL CDRS | CRYSTAL BIOSCIENCE INC. | 2019-10-24 | — | — | US | disclosed |
| WO-2019182751-A1 | TRANSGENIC CHICKEN THAT PRODUCES HUMAN ANTIBODIES | CRYSTAL BIOSCIENCE INC. (US) | 2019-09-26 | — | — | WO | disclosed |
| US-6322986-B1 | Method for colorectal cancer prognosis and treatment selection | ALBANY MEDICAL COLLEGE | 2001-11-27 | — | — | US | disclosed |
| EP-1117842-A1 | METHODS FOR SELECTING PROSTATE CANCER TREATMENTS AND TREATING PROSTATE CANCER | The Albany Medical College (US) | 2001-07-25 | — | — | EP | disclosed |
| WO-2001020033-A1 | METHODS FOR SELECTING PROSTATE CANCER TREATMENTS AND TREATING PROSTATE CANCER | THE ALBANY MEDICAL COLLEGE (US) | 2001-03-22 | — | — | WO | disclosed |
| EP-1000172-A1 | DETECTION OF TARGETS WITH GREEN FLUORESCENT PROTEIN AND FLUORESCENT VARIANTS THEREOF | ONCOR, INC. (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-0975803-A1 | METHOD FOR ASSESSING PROSTATE CANCER | ALBANY MEDICAL COLLEGE (US) | 2000-02-02 | — | — | EP | disclosed |
| US-5994071-A | MEASURING AMPLIFICATION LEVELS OF A TYROSINE KINASE GROWTH FACTOR REGULATOR GENE IN TISSUE SAMPLES USING FLUORESCENCE IN SITU HYBRIDIZATION, EVALUATING LEVELS WITH A REFERENCE LEVEL OF NORMAL CELLS; INCREASED LEVELS INDICATE RECURRENCE | ALBANY MEDICAL COLLEGE (US) | 1999-11-30 | — | — | US | disclosed |
| WO-1998045479-A1 | METHOD FOR ASSESSING PROSTATE CANCER | ALBANY MEDICAL COLLEGE (US) | 1998-10-15 | — | — | WO | disclosed |
| WO-1998036099-A1 | DETECTION OF TARGETS WITH GREEN FLUORESCENT PROTEIN AND FLUORESCENT VARIANTS THEREOF | ONCOR, INC. (US) | 1998-08-20 | — | — | WO | disclosed |